Disclosures. The Doctor in 2012: Quality, Accountability and Cost 5/30/2012. Challenges for the CV Profession

Similar documents
PCI Guidelines: Essentials for Understanding the Appropriate Use Criteria. J. Jeffrey Marshall, MD, FSCAI

Guidelines/Appropriateness ARCH 2015 St Louis, Missouri April 9-11, 2015 Manish A. Parikh, MD, FACC,FSCAI

Treatment Options for Angina

Improving on AUC. Presenter Disclosure Information. Objectives 3/13/2014. Cornelia Anderson BSN, RN. No Disclosures

Physician Self-referral and Health Care Utilization. Rita F. Redberg, MD, MSc Professor of Medicine UCSF Medical Center

CLINICAL PRACTICE GUIDELINES AND APPROPRIATE USE CRITERIA

Experts weigh in with their opinions of a new analysis looking at crossover patients.

Appropriateness of Percutaneous Coronary Interventions in Washington State

FFR-CT Not Ready for Primetime

Overview. Health and economic burden of coronary artery disease (CAD) Pitfalls in care of patients suspected of having CAD

Diabetes and Occult Coronary Artery Disease

SACHIN H. JAIN, MD, MBA Merck; Boston VA Medical Center; Department of Health Care Policy, Harvard Medical School

Do stents deserve the bad press? Mark A. Tulli MD, FACC

Cardiac Catheterization & Stent Implantation

Reducing the Population Health Burden of Cardiovascular Disease

Convincing the Payers. Saurabh Jha MBBS Assistant Professor of Radiology, University of Pennsylvania

Right Patient, Right Test, Right Time Clinical Use of Appropriate Use Criteria

CLINICAL SYMPTOMS AND ANGIOGRAPHIC FINDINGS OF PATIENTS UNDERGOING ELECTIVE CORONARY ANGIOGRAPHY WITHOUT PRIOR STRESS TESTING. Mouin S.

The NCDR and Clinical Practice Guideline Development

SYNTAX III REVOLUTION Trial Press briefing conference. Prof. Patrick W. Serruys MD, PhD Principal Investigator Imperial College of London

Imaging ischemic heart disease: role of SPECT and PET. Focus on Patients with Known CAD

Code Blue Resuscitating the External Peer Review Process to Improve Quality of Care and Decrease Hospital Risk

Version 4.4. Institutional Outcomes Report 2014Q3. National Outcomes Report Aggregation Date: Jan 12, :59:59 PM

David A. Orsinelli, MD, FACC, FASE Professor, Internal Medicine The Ohio State University Division of Cardiovascular Medicine Columbus, Ohio

Controversies in Cardiac Surgery

Can we use the health care workforce more efficiently? Insights from variations in practice

CABG vs PCI: What do the Guidelines Say?

Κλινική Χρήση IVUS και OCT PERIKLIS A. DAVLOUROS ASSOCIATE PROFESSOR OF CARDIOLOGY INVASIVE CARDIOLOGY & CONGENITAL HEART DISEASE

Evaluation of Intermediate Coronary lesions: Can You Handle the Pressure? Jeffrey A Southard, MD May 4, 2013

Application of Appropriate Use Criteria in Clinical Care of CAD. Peter K. Smith, MD Professor and Chief Thoracic Surgery Duke University 4/29/2012

Trends in PCI Utilization: Will there be a job for you?

VCU Pauley Heart Center: A 2009 US News Top 50 Heart and Heart Surgery Hospital

Controversies in Coronary Revascularization. Atlanta CCU April 15, 2016

CHOOSING WISELY CANADA DE-IMPLEMENTING LOW VALUE CARE

Coronary Artery Disease: Revascularization (Teacher s Guide)

Advances in Cardiovascular Diagnosis and Therapy. No disclosure or conflicts. Outline

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY

PCIs on Intermediate Lesions NCDR Cath-PCI Registry

Quality of Life After Everolimus- Eluting Stents or Bypass Surgery for Treatment of Left Main Coronary Artery Disease:

National Cardiovascular Data Registry

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Efficiency

What are the most common clinical scenarios that cause a PCI case to be deemed INAPPROPRIATE by AUC?

Journal of the American College of Cardiology Vol. 46, No. 8, by the American College of Cardiology Foundation ISSN /05/$30.

FFR in Multivessel Disease

2/26/2013. Appropriateness Use Criteria (Drilldown) Disclosures. Tony Hermann has nothing to disclose. Mark Hutcheson has nothing to disclose

2/20/2013. Why use imaging in CV prevention? Update on coronary CTA in 2013 Coronary CTA for 1 0 prevention: pros and cons Are we there yet?

Assessing Myocardium at Risk: Applying SYNTAX

R&M Solutions

Cardiac evaluation for the noncardiac. Nathaen Weitzel MD University of Colorado Denver Dept of Anesthesiology

Why have interventional cardiologists salaries

Comparing Effectively: The Role of Registries in Comparative Effectiveness Research

The International SHAPE Accreditation and Early Detection Program Report

FFR-Guided PCI. 4 th Imaging and Physiology Summit October 29 th, 2010 Seoul, Korea. Stanford

Team members: Felix Krainski, Besiana Liti, William Lane Duvall (ASNC member)

Surgery Grand Rounds

Supplementary Online Content

What do the guidelines say?

2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease

The Future of Cardiac Care: Managing Our Patients Together

PCI for Stable Ischemic Heart Disease: What Happened in the Last Week?

Expiring Medicare Provider Payment Policies. United States House of Representatives Committee on Ways and Means Subcommittee on Health

Physician Beliefs and Patient Preferences: A New Look at Regional Variation in Spending

Carotid Artery Disease How the Data Will Influence Management The Symptomatic vs. the Asymptomatic Patient

Left Main Intervention: Will it become standard of care?

Welcome! To submit questions during the presentation: or Text:

By: Diamond Fernandes BSc, ACSM CES, CSCS To learn more about the author, click below

ACCF/SCAI/STS/AATS/AHA/ASNC/HFSA/SCCT 2012 Appropriate Use Criteria for Coronary Revascularization Focused Update

Clinical case in perspective. Cases from Poland

Σεμινάριο Ομάδων Εργασίας Fractional Flow Reserve (FFR) Σε ποιούς ασθενείς; ΔΗΜΗΤΡΗΣ ΑΥΖΩΤΗΣ Επιστ. υπεύθυνος Αιμοδυναμικού Τμήματος, Βιοκλινική

Fractional Flow Reserve: Basics, FAME 1, FAME 2. William F. Fearon, MD Associate Professor Stanford University Medical Center

CT FFR: Are you ready to totally change the way you diagnose Coronary Artery Disease?

COURAGE to Leave Diseased Arteries Alone

The Evolving ACC-NCDR Programs: What you need to know for your practice

Current and Future Imaging Trends in Risk Stratification for CAD

Update : Carotid Stenting and Current Trial Data

Submitted to the House Energy and Commerce Committee. Federal Efforts to Combat the Opioid Crisis

INDIVIDUALIZED MEDICINE

GRAND ROUNDS - DILEMMAS IN ANTICOAGULATION AND ANTIPLATELET THERAPY. Nick Collins February 2017

Treatment of Cardiovascular Risk Factors. Kevin M Hayes D.O. F.A.C.C. First Coast Heart and Vascular Center

Ischemic Heart Disease Interventional Treatment

How to investigate (Cardiac) Chest Pain

DIAGNOSTIC BUNDLES MOVING THE SPECIALIST TO VALUE

Percutaneous Coronary Interventions Without On-site Cardiac Surgery

Imaging Utilization: The Radiology perspective

Chronic Total Occlusions Rajan Patel, MD FACC FAHA FSCAI

Registry Assessment of Peripheral Interventional Devices (RAPID)

Master Class in Preventive Cardiology Focus on Diabetes and Cardiovascular Disease Geneva April

Medical Rx vs PCI vs CABG

Assessing Cardiac Risk in Noncardiac Surgery. Murali Sivarajan, M.D. Professor University of Washington Seattle, Washington

Management of High-Risk Coronary Artery Disease

TREATMENT OF HIGHER RISK PATIENTS INTRODUCTION TO PROTECTED PCI WITH IMPELLA. IMP v4

News the. Methods Data collection. The NCDR is a national registry of patients undergoing diagnostic cardiac catheterizations

Left Main Intervention: Where are we in 2015?

ADVANCING HEALTH CARE QUALITY IN 2007 AND BEYOND. Margaret E. O Kane President National Committee for Quality Assurance

FFR Incorporating & Expanding it s use in Clinical Practice

PAD Characterization Within A Healthcare System" RAPID Face-to-Face Meeting Schuyler Jones, MD September 14, 2016

Advancing Cardiovascular Care of the Oncology Patient

Rationale for Left Ventricular Support During Percutaneous Coronary Intervention

Risk Classification Modeling to Combat Opioid Abuse

Coronary stenting: the appropriate use of FFR

Transcription:

Defining Appropriate Use of Percutaneous Coronary Revascularization in 2012 9 th Annual ACC Oregon Chapter Cardiovascular Symposium June 3, 2012 Ralph Brindis, MD, MPH, MACC, FSCAI Senior Advisor for Cardiovascular Disease, N. Cal. Kaiser Permanente Clinical Professor of Medicine, UCSF Past President, American College of Cardiology Challenges for the CV Profession Changes in CV Practice & Health Care Reform Demand for Measurement of Quality Demand for Public Reporting & Transparency Demand for Assuring Responsible CV Innovation Diffusion Demand for Appropriate Use of CV Care Disclosures The Doctor in 2012: Quality, Accountability and Cost I am a Recovering Interventional Cardiologist Sir Luke Fildes, 1887, The Tate Museum, London Societal Perceptions of Clinicians Knight or Knightess??? 1

Societal Perceptions of Clinicians Knaves??? If Clinicians are Knaves Policy, management and educational efforts designed to combat and work against clinicians and not for them Self-interest/financial gain first; patients secondary Need rewards and incentives to motivate Monitoring for abuse, fraud and waste required Learn new techniques/procedures for personal gain Research for self-glorification and narcissism Health care system functions in spite of not due to them Regulations guard against malfeasance and need for public protection Jain & Cassel JAMA 2010;304:1009-1110 Societal Perceptions of Clinicians Clinicians viewed as Knaves & Pawns NOT Knights - Implications Behavior tied to rising healthcare costs and increased scrutiny over quality of care: Clinician viewed an obstacle not an enabler to functioning health care system Pawns??? Rather than by our professional ethic, need to be guided strict regulations or incentive payments If Clinicians are Knights Knighthood the definition of Professionalism Stewardship for Healthcare system in our hands Trusted to practice Appropriate Use of resources Champion of patients and policies to support our work Save and improve lives, financial gain is secondary Continuing education and clinical and basic research Respected advisor for policy and payment when policy affects health of public Clinicians viewed as Knaves & Pawns NOT Knights - Implications Views of unwarranted variations in care, evidence of waste and occasionally fraud The modern clinician in the United States now regarded at times as a Knave or a Pawn - rather than a Knight!! Jain & Cassel JAMA 2010;304:1009-1110 2

Interventional Cardiology 2006-2012 Despite All the Advances in Interventional Cardiology During the Past 33 years... "Most [cardiologists] haven't voluntarily incorporated the Courage criteria into their practice. What's going to continue to drive practice is reimbursement. William Boden, MD, FACC (WSJ, 2/11/10) "Bill Boden has been telling me, we're looking at a potential of $8 billion in savings," across the country Cynthia Ambres, the chief medical officer of HealthNow New York Inc. (WSJ, 2/11/10) We Have an Image Problem Variation in Care PCI Rates per 1,000 Medicare Enrollees (2002-03) Redding, CA McAllen, TX http://www.dartmouthatlas.org/ 13.5 to 38.1 (63) 11.5 to < 13.5 (53) 10.0 to < 11.5 (75) 8.5 to < 10.0 (53) 3.5 to < 8.5 (62) Not Populated Bad News Gets All the Press Attention Variation in the Use of PCI vs. CABG February 4, 2009 US average is 2.6 PCIs for each CABG http://www.dartmouthatlas.org/ 3

Donald Berwick, MD Was your Stent Unnecessary? Past President and CEO, Institute for Healthcare Improvement Administrator, CMS: 7/10 12/11 Unintended variation is stealing healthcare blind 20-30% of health spending is waste with no benefit to patients, because of overtreatment, failure to coordinate care, administrative complexity and fraud A Poignant Example of Overuse in CABG Redding, CA Did Dr. Oz Get it Right? 50% of all PCIs are inappropriate Decision Making in PCI: Cascade Effect The Patient INFLUENCES ON PATIENTS Symptoms Quality of Life Patient anxiety Expectations Founded and unfounded Asymptomatic screening Family member/friend with CAD Celebrity Tim Russert Public awareness campaigns Media reports new tests/studies Financial accountability Costs and co-pays PATIENT PCP CARDIOLOGIST SELF- REFERRAL Adapted from: Lin and Redberg, Archives Int Med 2007 4

Patient Expectations About Elective PCI 52 consecutive patients scheduled for first elective PCI completed semi-structured questionnaire prospectively Do you think the angioplasty will prevent a heart attack? Yes 75% Do you think the angioplasty will help you live longer? Yes 71% Holmboe et al. J Gen Intern Med 2000;15:632. John F. Kennedy in a 1959 campaign speech: When written in Chinese the word crisis is composed of two characters. One represents danger, and the other represents opportunity Physician Decision Making in PCI: Cascade Effect PATIENT Appropriate Use Criteria INFLUENCES ON PCPs Fear of missing a lesion Perception of patient anxiety and expectations Medicolegal liability Uncertainty about best treatment leads to referral Lin and Redberg, Archives Int Med 2007 PCP CARDIOLOGIST PCI SELF-REFERRAL TESTING & REFERRAL CATHETERIZATION INFLUENCES ON CARDIOLOGISTS Fear of missing a lesion Perception of patient anxiety and expectations Belief in the open artery hypothesis and the benefits of PCI Oculo-stenotic reflex Medico-legal liability Because: 1)There are continuing and reasonable questions about what we do 2)If we don t do this,..... someone else will 3)We need to be at the table and not on the menu!!!!!!!!! J Am Coll Cardiol 2012 Available at http://www.acc.org Potential Impact of Inappropriate PCI Why? 700,000 PCI/year in US 5% inappropriate and 12% uncertain (NCDR) 25% of uncertain PCI are? inappropriate Professional Responsibility Commitment to Quality We can do it better than anyone else >200 deaths avoidable by eliminating inappropriate PCI Components of quality include appropriateness of case selection A quality program performs appropriately selected procedures - 2005 ACC/AHA/SCAI PCI Guidelines 5

Right Patient High Quality Cardiovascular Procedures Patient Preferences Appropriate Use Criteria Clinical Guidelines Right Procedure Decision Ongoing trials and evidence Right Procedure Execution Quality Metrics Public Reporting Right Outcome Performance Measures Value equation for cardiovascular procedures was the right procedure done in the right way with the right outcome in a timely fashion? Measures (AUC / Outcome Measures) ACC AUC Goals Where practice patterns of individuals and/or hospitals routinely conflict with AUC ratings, further evaluation and education should be considered Ultimate objective of AUC is to encourage cardiologists to take leadership and provide direction to optimize quality and safety of care and lower cost even when improving health outcomes Opportunities for cost savings are obvious What are Appropriateness Criteria? Development of CPG s, Performance Measures, and Appropriate Use Documents Antman, Antman, Circulation Circulation 2009:119:1180-1185. Define what to do, when to do, and how often to do in the context of local care environments combined with patient and family preferences and values Address misuse, overuse and underuse Connected to guideline content Imply a level of detail and complexity that extends beyond the current recommendations ACC AUC Goals Partner with clinicians, health plans, policymakers and payers for rational/fair use and reimbursement for CV Dx and Rx Blend evidence-base and clinical experience data, congruent with CPGs Recognize that some ambiguity is intrinsic to clinical decision making AUC is not a substitute for sound clinical judgment or patient preference Steward equitably and efficiently limited U.S. health care resources Appropriateness Use Criteria Developed Using a Modified Rand/Delphi Methodology Define Appropriateness for Coronary Revascularization Coronary revascularization is appropriate when the expected benefits, in terms of survival or health outcomes (symptoms, functional status, and/or quality of life) exceed the expected negative consequences of the procedure 6

Developing the Appropriateness Use Criteria The Writing Committee The Technical Panel Nominated by professional societies Selected for balance by the writing committee and Task Force 4 interventional cardiologists 4 CT surgeons 8 cardiologists 1 Health plan officer Define appropriateness Preliminary CPG & literature search Assumptions & definitions Developed 180 clinical scenarios Scenarios critiqued by all organizations Scenarios modified and improved & In-depth literature, CPG search Most examine the appropriateness of revascularization Low-Risk Findings on Noninvasive Imaging Study And Asymptomatic (Patients Without Prior Bypass Surgery) Non-invasive testing Symptoms/Rx Burden of disease Appropriateness Definitions Appropriate rating Definite or Probable benefit of PCI for the indication Clinical Scenarios Patients without prior CABG Class I or II, high risk findings regardless of med Rx Intermediate risk findings, severe Sx or max Rx Revascularization = Uncertain rating Possible benefit of PCI for the indication Inappropriate rating Unlikely benefit for the indication Framework for Decision Making STEMI Five Core Variables Class IV High risk Max LM + 3v CAD A Clinical Scenarios Patients without prior CABG Class III or IV, high risk findings regardless of med Rx = Revascularization STABILITY SYMPTOMS ISCHEMIA MEDICAL Rx ANATOMY U Stable angina Class I ASx None Low risk None No sig. CAD I 7

Advanced CAD Method of Revascularization Angina Class III, and/or evidence of intermediate or high risk non-invasive features Note: 2009 ratings created pre- 2012 SYNTAX AUC And Revasc ISAR Left Main Update Challenges with Appropriateness Use Ratings Rely on collection of currently unavailable clinical data to map patients to appropriateness ratings Can the data always be collected? Can patients be mapped to the prototypical scenarios? Still being validated - AUC implementation will provide pragmatic, observational research opportunities to study outcomes in specific populations No data yet demonstrating equal, improved, or worse outcomes with AUC implementation Over-Simplification of Clinical Reality Currently, 198 clinical scenarios Do not capture unique patient and coronary anatomic factors If age, DM, severe CKD added more than 2,000 clinical scenarios impractical to implement AUC are a test metric and will be refined Optimal rate is not necessarily 0% 8